Presented
by

Presented by Oxford Global

Discover PLUS Pass

All Discovery Content

Bringing you the latest research in Drug Discovery In New Modalities, Integration Of DEL, Covalent Inhibitors, Protein Degradation Technologies, Computational Drug Design & Automation Strategies and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Whitepaper
Pivot Park Screening Centre: We Help You to Accelerate Drug Discovery
Are you looking for lead candidate compounds for your target or cellular phenotype, and do you want your drug discovery program to be more efficient, both in terms of time and cost?
Edited by Tom Cohen |
16 November 2023
Target Based Discovery
Whitepaper
Bundle Cultrex™ BME with Select Proteins & Save
Use Promo Code: PROTBME15 to receive 15% off your order
21 June 2023
Target Based Discovery
Whitepaper
Biotechne: Service and Support Plans
Proteinsimple, a bio-techne brand, is here to support your research at every step of the way.
21 June 2023
Target Based Discovery
Whitepaper
Biotechne: Your Complete Protein Analysis Solution
Protein analysis comes with many challenges—labor-intensive protocols increase time to result and multiple hands-on steps increase user error and data variability
21 June 2023
Target Based Discovery
Whitepaper
Biotechne: Your Complete Protein Analysis Solution
Simple Western With Jess
21 June 2023
Target Based Discovery
Whitepaper
Tailor-made ADME-Tox
Admescope is a contract research organisation (CRO) providing the pharmaceutical industry with tailor-made ADME-Tox services to support the discovery and development of small molecules and biologics.
21 June 2023
Target Based Discovery
Whitepaper
Admescope: a Symeres Company
Your ADME-Tox Research Partner
21 June 2023
Target Based Discovery
Industry Spotlight
Potential Antidote Discovered for Centuries-Old Toxic Mushroom
Researchers have discovered a potential antidote, indocyanine green (ICG), for the highly toxic death cap mushroom, Amanita phalloides.
Edited by Tom Cohen |
18 May 2023
Target Based Discovery
Insight Article
Navigating DEL Screening from Hit to Lead
The panel at Drug Discovery US discussed hit finding technologies, protein availability for screening, and hit-to-lead transition.
Edited by Tom Cohen |
05 April 2023
Target Based Discovery
Industry Spotlight
First Paediatric Patients Enrolled in Phase III Clinical Trial for Rare Genetic Disease
A clinical trial for the drug leniolisib will go ahead in studying paediatric patients with the rare genetic disease ADPS.
Edited by Tom Cohen |
21 February 2023
Target Based Discovery

Search by Keyword

Filter by Subject Area

Discovery Series – Subject

Filter by Content Type

Resource Formats (incl. Industry Spotlight)

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.